CIC
FATE icon

Cornercap Investment Counsel’s Fate Therapeutics FATE Stock Holding History

Cornercap Investment Counsel’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,683
Closed -$72.4K – 492
2024
Q3 		$72.4K Sell
20,683
-22,789
-52% -$88.7K 0.02% 496
2024
Q2 		$143K Sell
43,472
-340
-0.8% -$1.49K 0.02% 560
2024
Q1 		$322K Buy
43,812
+2,475
+6% +$15.3K 0.05% 511
2023
Q4 		$155K Hold
41,337
– – 0.03% 546
2023
Q3 		$87.6K Sell
41,337
-526
-1% -$1.74K 0.02% 539
2023
Q2 		$199K Hold
41,863
– – 0.03% 515
2023
Q1 		$239K Buy
+41,863
New +$253K 0.04% 484

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return